Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-BS0007
Host Cell : CHO-K1 Size : >1x106 frozen cells/vial
| Cat. No. | CSC-BS0007 |
| Description | This cell line is engineered to stably produce Infliximab which is a monoclonal antibody against human TNF-a. |
| Target Gene | Infliximab |
| Host Cell | CHO-K1 |
| Host Cell Species | Cricetulus griseus (Chinese hamster) |
| Applications |
1. Biosimilar Development 2. Large-Scale Biomanufacturing 3. Preclinical Research 4. Drug Development and Testing |
| Size | >1x106 frozen cells/vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Growth Conditions | 37° C, 5% CO2 |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
A: Infliximab is a monoclonal antibody drug used to treat autoimmune diseases.
A: Infliximab targets a molecule called tumor necrosis factor alpha (TNF alpha) which is produced in excess in the immune system in several autoimmune disorders.
A: Infliximab is a widely used drug and has been approved by the US FDA for several indications including rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
A: This cell line has several advantages, including a high proliferation rate, stability, and well-characterization.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Great buy! The use of infliximab stable cell lines can significantly increase production efficiency over conventional methods.
These infliximab cells have a high proliferation rate, and they can be easily grown in large quantities for the production of Infliximab.
Creative Biogene's Infliximab cells are highly stable, there they can maintain their genetic integrity and infliximab production capabilities over multiple generations.
Infliximab Stable Cell Line makes it easier to optimize the production of infliximab and to achieve high yields. I recommend it.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.